Indoco's Baddi Plant III gets EU GMP Certification
Indoco Remedies Ltd. announced that its Oral Solid Dosage (OSD) manufacturing facility (Plant III) located at Baddi, Himachal Pradesh, has received EU GMP certification from the German Health Authority (Berlin). The inspection was conducted from April 22 to April 27, 2026. This certification confirms that the facility adheres to the Good Manufacturing Practice requirements as outlined in the EC Directive. Ms. Aditi Panandikar, Managing Director, highlighted that this certification underscores the company's dedication to delivering high-quality products to patients worldwide. Indoco is a fully integrated pharmaceutical company with a strong global presence and multiple manufacturing facilities approved by various regulatory authorities, including USFDA and UK-MHRA.
Key Highlights
- Indoco's Baddi Plant III received EU GMP certification from German Health Authority.
- The certification confirms compliance with Good Manufacturing Practice requirements.
- Enhances Indoco's capability to supply high-quality products to global markets.
- Strengthens the company's regulatory standing for international operations.
Price Impact
More from INDOCO